1. 2079. Comparison of Recency Assays to Estimate HIV Incidence in the SIENA (eStimating hIv incidEnce amoNg Agyw) Study in Uganda. (15th December 2022) Authors: Cox, Stephanie; Kintu, Alexander; Shao, Yongwu; Kiweewa, Flavia Matovu; Lukyamuzi, Zubair M; Kiweewa, Francis; Facente, Shelley N; Grebe, Eduard; Ebrahimi, Ramin; Carter, Christoph C; Callebaut, Christian; Baeten, Jared; Das, Moupali Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 854. Long-term Outcomes of Participants on F/TAF for Pre-Exposure Prophylaxis: Results for 144 Weeks of Follow-Up in the DISCOVER Trial. (4th December 2021) Authors: Ramgopal, Moti; Ruane, Peter; Shao, Yongwu; Ebrahimi, Ramin; Kintu, Alex; Carter, Christoph C; Das, Moupali; Baeten, Jared; Brinson, Cynthia; Shalit, Peter; Mounzer, Karam Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S517 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 854. Long-term Outcomes of Participants on F/TAF for Pre-Exposure Prophylaxis: Results for 144 Weeks of Follow-Up in the DISCOVER Trial. (4th December 2021) Authors: Ramgopal, Moti; Ruane, Peter; Shao, Yongwu; Ebrahimi, Ramin; Kintu, Alex; Carter, Christoph C; Das, Moupali; Baeten, Jared; Brinson, Cynthia; Shalit, Peter; Mounzer, Karam Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S517 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 985. Impact of Age and Medical Comorbidities on Renal Outcomes in the DISCOVER Trial. (31st December 2020) Authors: Daar, Eric; Brunetta, Jason; Cua, Eric; Flamm, Jason; Asmuth, David; Carter, Christoph C; Shao, Yongwu; Wong, Pamela; Ebrahimi, Ramin; Das, Moupali; Brainard, Diana M; Clarke, Amanda Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 995. Safety and Efficacy of F/TAF and F/TDF for PrEP in DISCOVER Participants Taking F/TDF for PrEP at Baseline. (31st December 2020) Authors: Campbell, Thomas; Clarke, Amanda; Trottier, Benoit; Carter, Christoph C; Shao, Yongwu; Ebrahimi, Ramin; Das, Moupali; Brainard, Diana M; Gladstein, Jay Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 7 (July 2021) Authors: Ogbuagu, Onyema; Ruane, Peter J; Podzamczer, Daniel; Salazar, Laura C; Henry, Keith; Asmuth, David M; Wohl, David; Gilson, Richard; Shao, Yongwu; Ebrahimi, Ramin; Cox, Stephanie; Kintu, Alexander; Carter, Christoph; Das, Moupali; Baeten, Jared M; Brainard, Diana M; Whitlock, Gary; Brunetta, Jason... Journal: Lancet Issue: Volume 8:Issue 7(2021) Page Start: e397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pharmacokinetic drug–drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus. Issue 2 (22nd January 2015) Authors: Zack, Julia; Berg, Jolene; Juan, Axel; Pannacciulli, Nicola; Allard, Martine; Gottwald, Mildred; Zhang, Heather; Shao, Yongwu; Ben‐Yehuda, Ori; Jochelson, Phil Journal: Clinical pharmacology in drug development Issue: Volume 4:Issue 2(2015:Mar./Apr.) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Randomized study evaluating the efficacy and safety of switching from an an abacavir/lamivudine-based regimen to an elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide single-tablet regimen. (1st August 2019) Authors: Rizzardini, Giuliano; Gori, Andrea; Miralles, Celia; Olalla, Julián; Molina, Jean-Michel; Raffi, François; Kumar, Princy; Antinori, Andrea; Ramgopal, Moti; Stellbrink, Hans-Jürgen; Das, Moupali; Chu, Hoa; Ram, Renee; Garner, Will; Shao, Yongwu; Chuck, Susan K.; Piontkowsky, David; Haubrich, Richa... Journal: AIDS Issue: Volume 33:Number 10(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial. Issue 12 (December 2016) Authors: Gaur, Aditya H; Kizito, Hilda; Prasitsueubsai, Wasana; Rakhmanina, Natella; Rassool, Mohammed; Chakraborty, Rana; Batra, Jagmohan; Kosalaraksa, Pope; Luesomboon, Wicharn; Porter, Danielle; Shao, Yongwu; Myers, Michael; Ting, Lillian; SenGupta, Devi; Quirk, Erin; Rhee, Martin S Journal: Lancet Issue: Volume 3:Issue 12(2016) Page Start: e561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety, efficacy, and pharmacokinetics of single-tablet elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed, HIV-infected children: a single-arm, open-label trial. (September 2017) Authors: Natukunda, Eva; Gaur, Aditya H; Kosalaraksa, Pope; Batra, Jagmohan; Rakhmanina, Natella; Porter, Danielle; Shao, Yongwu; Zhang, Heather; Pikora, Cheryl; Rhee, Martin S Journal: Lancet Issue: Volume 1:Number 1(2017) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗